As a sub-discipline of biological science, synthetic biology is known as the "third biological science revolution" after the discovery of DNA double helix structure and genome sequencing.
This article is the "Profitability" part of the enterprise value series, and a total of 24 synthetic biology companies are selected as research samples, and the return on net assets, gross profit margin, net profit margin, etc. are used as evaluation indicators.
The data is based on history, does not represent future trends, is for static analysis only and does not constitute investment advice.
Top 10 Synthetic Biology Profitability Companies:
10th Azure Creature
Profitability: Return on equity 6.18%, gross profit margin 45.24%, net profit margin 9.65%
Main products: enzymes are the main source of income, accounting for 36.82% of revenue, and gross profit margin is 60.80%
Company Highlights: Blue Biotech attaches great importance to the research and development of synthetic biology, has established a synthetic biology laboratory, and has carried out a number of work in the field of synthetic biology.
9th Luculent environment
Profitability: Return on equity 11.95%, gross profit margin 26.04%, net profit margin 13.13%
Main products: Biomass resource recycling business is the main source of income, accounting for 96.21% of revenue and gross profit margin of 25.93%
Company Highlights: Luculent is planning to build a synthetic biology intelligent manufacturing center to develop synthetic biology products such as PHAs (bio-based new materials) and HMOs (human milk oligosaccharides) by using synthetic biology technology.
8th Gloria Young
Profitability: Return on equity 17.77%, gross profit margin 47.62%, net profit margin 27.98%
Main products: CDMO solutions in the commercialization stage are the main source of revenue, accounting for 65.33% of revenue and gross profit margin of 60.07%
Company Highlights: Gloria has set up a synthetic biotechnology R&D center (CSBT) and has established a mature one-stop synthetic biology service capability starting from molecular biology (recombinant expression).
7th Carbigous
Profitability: Return on equity 6.81%, gross profit margin 44.87%, net profit margin 23.69%
Main products: ARA products are the main source of revenue, accounting for 73.12% of revenue, and gross profit margin of 44.95%
Company Highlights: Jiabiyou is one of the earliest high-tech enterprises engaged in the production of polyunsaturated fatty acids and fat-soluble nutrients by microbial synthesis in China.
6th Yaxiang shares
Profitability: Return on equity 9.92%, gross profit margin 33.86%, net profit margin 15.26%
Main products: Cooling agent is the main source of revenue, accounting for 46.28% of revenue, and gross profit margin of 33.94%
Company Highlights: Yaxiang attaches great importance to the development and application of synthetic biotechnology in spices.
5th Angel yeast
Profitability: Return on equity 16.68%, gross profit margin 25.44%, net profit margin 10.85%
Main products: yeast and deep-processed products are the main source of income, accounting for 69.99% of revenue, and gross profit margin of 30.65%
Company Highlights: Angel Yeast and Beijing Microstructure Factory jointly established Weiqi Biotechnology, and the 10,000-ton polyhydroxyalkanoate industrialization project jointly promoted is in normal progress.
4th Garden Creatures
Profitability: Return on equity 13.05%, gross profit margin 64.86%, net profit margin 30.10%
Main products: Pharmaceuticals are the main source of income, accounting for 52.28% of revenue, and gross profit margin is 74.05%
Company Highlights: Garden Biology has entered the biological industry chain and started the dual layout of chemical synthesis and biosynthesis.
3rd Twining Biotech
Profitability: Return on equity 8.32%, gross profit margin 26.19%, net profit margin 11.24%
Main products: Pharmaceutical intermediates are the main source of revenue, accounting for 92.20% of revenue, and gross profit margin of 33.21%
Company Highlights: Twining Biotech focuses on health care product raw materials, biopesticides, high value-added natural products, high-end cosmetic raw materials and other sectors, and has several products such as bisabolol, pentahydroxytryptophan, and ergothioneine.
No. 2 Puluo Pharmaceuticals
Profitability: Return on equity 19.20%, gross profit margin 25.37%, net profit margin 9.76%
Main products: API intermediates are the main source of revenue, accounting for 69.61% of revenue, and gross profit margin is 17.56%
Company Highlights: Puluo Pharmaceutical has established a synthetic biology and enzyme catalytic engineering technology platform, and has applied synthetic biotechnology in some projects.
1st club creature
Profitability: Return on equity 28.58%, gross margin 21.38%, net profit margin 12.54%
Main products: animal nutrition amino acids are the main source of income, accounting for 52.37% of revenue, and gross profit margin of 12.22%
Company Highlights: Meihua Bio is a full-chain synthetic biology company mainly engaged in amino acid products, and its core competence covers all aspects from strain design, construction, fermentation, separation and extraction to products.
The top 10 companies in terms of profitability of synthetic biology, return on net assets, gross profit margin and net profit margin in the past three years:
